Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Tg Therapeutics Inc (TGTX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q1 | 0 | 0.00 | Sell 100.00% | 1.20 | SEC | ||
| 2022 Q4 | 4,318,700 | 1.20 | Reduce 43.93% | 0.46 | $11.83 | $51,090,221 | SEC |
| 2022 Q3 | 7,701,870 | 1.04 | Add 14.14% | 0.13 | $5.92 | $45,595,000 | SEC |
| 2022 Q2 | 6,747,549 | 0.71 | Add 1.05% | <0.01 | $4.25 | $28,677,000 | SEC |
| 2022 Q1 | 6,677,726 | 1.15 | Add 10.65% | 0.11 | $9.51 | $63,505,000 | SEC |
| 2021 Q4 | 6,034,875 | 1.30 | Add 83.07% | 0.59 | $19.00 | $114,663,000 | SEC |
| 2021 Q3 | 3,296,451 | 1.11 | Add 16.85% | 0.16 | $33.28 | $109,706,000 | SEC |
| 2021 Q2 | 2,821,079 | 1.04 | Reduce 5.05% | 0.07 | $38.79 | $109,430,000 | SEC |
| 2021 Q1 | 2,971,136 | 1.31 | Reduce 7.21% | 0.19 | $48.20 | $143,209,000 | SEC |
| 2020 Q4 | 3,202,061 | 2.67 | Reduce 27.10% | 0.59 | $52.02 | $166,571,000 | SEC |
| 2020 Q3 | 4,392,196 | 2.18 | Add 3,277.60% | 2.12 | $26.76 | $117,535,000 | SEC |
| 2020 Q2 | 130,039 | 0.05 | Buy | 0.05 | $19.48 | $2,533,000 | SEC |